Synthetic Medical is an innovative medical technology enterprise dedicated to the cardiac electrophysiology sector, founded in 2007. Originated from Synthetic Medical established in Minnesota, the United States in 2005, the company devotes itself to delivering comprehensive diagnosis and treatment solutions for cardiovascular diseases such as tachyarrhythmia.
As a national high-tech enterprise and a national-level Specialized, Refined, Differential and Innovative "Little Giant" enterprise, it operates R&D and manufacturing bases in both China and the United States. Its product portfolio covers core segments including transseptal puncture devices, diagnostic catheters, therapeutic catheters and cryoablation systems.
Through independent innovation, the company has broken the long-term monopoly of international giants in the electrophysiology industry. Its transseptal puncture devices are widely used in nearly 2,000 hospitals worldwide.
